463 related articles for article (PubMed ID: 11959564)
1. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Quenelle DC; Collins DJ; Kern ER
Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Smee DF; Bailey KW; Sidwell RW
Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
[TBL] [Abstract][Full Text] [Related]
4. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Smee DF; Bailey KW; Sidwell RW
Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
[TBL] [Abstract][Full Text] [Related]
5. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Wong M; Sidwell RW
Antiviral Res; 2000 Sep; 47(3):171-7. PubMed ID: 10974369
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro.
Keith KA; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 May; 48(5):1869-71. PubMed ID: 15105146
[TBL] [Abstract][Full Text] [Related]
7. Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.
Smee DF; Wandersee MK; Bailey KW; Hostetler KY; Holy A; Sidwell RW
Antivir Chem Chemother; 2005; 16(3):203-11. PubMed ID: 16004083
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
Quenelle DC; Collins DJ; Kern ER
Antiviral Res; 2004 Jul; 63(1):33-40. PubMed ID: 15196818
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of cidofovir resistant vaccinia viruses.
Becker MN; Obraztsova M; Kern ER; Quenelle DC; Keith KA; Prichard MN; Luo M; Moyer RW
Virol J; 2008 May; 5():58. PubMed ID: 18479513
[TBL] [Abstract][Full Text] [Related]
10. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
[TBL] [Abstract][Full Text] [Related]
11. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Smee DF; Bailey KW; Wong MH; Sidwell RW
Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2000 Jul; 11(4):303-9. PubMed ID: 10950392
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir in the treatment of poxvirus infections.
De Clercq E
Antiviral Res; 2002 Jul; 55(1):1-13. PubMed ID: 12076747
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.
Kornbluth RS; Smee DF; Sidwell RW; Snarsky V; Evans DH; Hostetler KY
Antimicrob Agents Chemother; 2006 Dec; 50(12):4038-43. PubMed ID: 16982794
[TBL] [Abstract][Full Text] [Related]
15. Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
Bray M; Martinez M; Kefauver D; West M; Roy C
Antiviral Res; 2002 Jun; 54(3):129-42. PubMed ID: 12062386
[TBL] [Abstract][Full Text] [Related]
16. Parapoxviruses are strongly inhibited in vitro by cidofovir.
Nettleton PF; Gilray JA; Reid HW; Mercer AA
Antiviral Res; 2000 Dec; 48(3):205-8. PubMed ID: 11164507
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice.
Neyts J; De Clercq E
J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505
[TBL] [Abstract][Full Text] [Related]
18. In vivo imaging of cidofovir treatment of cowpox virus infection.
Goff A; Twenhafel N; Garrison A; Mucker E; Lawler J; Paragas J
Virus Res; 2007 Sep; 128(1-2):88-98. PubMed ID: 17524511
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.
Altmann SE; Smith AL; Dyall J; Johnson RF; Dodd LE; Jahrling PB; Paragas J; Blaney JE
Antiviral Res; 2012 Feb; 93(2):305-308. PubMed ID: 22182595
[TBL] [Abstract][Full Text] [Related]
20. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections.
Baker RO; Bray M; Huggins JW
Antiviral Res; 2003 Jan; 57(1-2):13-23. PubMed ID: 12615299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
